Skip to main content

Table 2 Baseline Demographics

From: A randomized, controlled, single-blinded, multicenter evaluation of the efficacy and safety of a once weekly two dose otic gel containing florfenicol, terbinafine and betamethasone administered for the treatment of canine otitis externa

Demographic

Otic Gel

Otic Suspension

P-value

Age in years (mean ± SD)

6.2 ± 3.8

5.8 ± 3.7

0.46

Number of Male/Female (%)

55/45

53/47

0.72

Weight in kg (mean ± SD)

21.9 ± 14.4

22.8 ± 14.8

0.62

Bilateral otitis

103 (70%)

101 (74%)

0.51

Ceruminous exudate

108 (73%)

96 (70%)

0.60

Purulent exudate

40 (27%)

41 (30%)

Acute/subchronic/chronic

42 (28%), 87 (59%), 19 (13%)

30 (22%), 90 (66%), 17 (12%)

0.42

Number of days since onset (mean ± SD)

18.8 ± 22.8

18.6 ± 22.5

0.73

Previously treated

13 (9%)

17 (12%)

0.34

Recurrent

46 (31%)

46 (34%)

0.90

Culture yeast only (%)

25

27

0.89

Culture bacteria only (%)

22

20

Culture yeasts and bacteria (%)

39

42